Gyroscope Capital Management Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,381
Closed -$319K 106
2016
Q2
$319K Sell
1,381
-447
-24% -$103K 0.26% 61
2016
Q1
$490K Buy
1,828
+190
+12% +$54.4K 0.38% 48
2015
Q4
$512K Buy
1,638
+67
+4% +$19.9K 0.4% 45
2015
Q3
$427K Buy
1,571
+89
+6% +$27.3K 0.36% 46
2015
Q2
$450K Buy
1,482
+50
+3% +$14.9K 0.37% 49
2015
Q1
$426K Buy
1,432
+137
+11% +$39.1K 0.35% 41
2014
Q4
$333K Buy
+1,295
New +$324K 0.27% 49

Other funds holding AGN

Gyroscope Capital Management Group's AGN Position: Q3 2016 in Review

Gyroscope Capital Management Group sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 1,381 shares — an estimated $319K sold.

Gyroscope Capital Management Group first reported a position in AGN in Q4 2014 and held it in 7 quarters. The position peaked at $512K in Q4 2015. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Gyroscope Capital Management Group reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Gyroscope Capital Management Group sold 1,381 Allergan plc shares in Q3 2016, an estimated $319K.
  • Gyroscope Capital Management Group first reported a position in Allergan plc in Q4 2014 and held it in 7 quarters.
  • Gyroscope Capital Management Group's Allergan plc position peaked at $512K in Q4 2015.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Gyroscope Capital Management Group's 13F filing for Q3 2016, filed 10 Nov 2016.